跳至主要内容
临床试验/CTRI/2026/02/104530
CTRI/2026/02/104530尚未招募不适用

Comparison Between Dexmedetomidine And Remifentanil For Attenuation Of Hemodynamic Response To Laryngoscopy And Tracheal Intubation

Dr Shibani Kairi1 个研究点 分布在 1 个国家目标入组 210 人开始时间: 2026年3月6日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
210
试验地点
1

研究概览

简要总结

Laryngoscopy and endotracheal intubation are essential components of general anesthesia , facilitating airway control and mechanical ventilation .However these procedure are potent stimuli that can evoke marked sympathetic and hemodynamic response , characterized by tachycardia, hypertension and arrhythmias . These reflex cardiovascular changes result primarily from the stimulation of the supraglottic and subglottic structure , leading to a surge in catecholamine release mediated by sympathetic activation. Although transient in healthy individuals, these responses may have deleterious effects in cardiovascular or cerebrovascular disease, including myocardial ischemia ,heart failure exacerbation, or intracranial hypertension.

Dexmedetomidine selectively in alpha -2 adrenergic located in the locus coeruleus of the brainstem and peripheral sympathetic nerve terminals .Activation of these receptors results in the inhibition of norepinephrine release, decrease sympathetic activity ,and enhancement of parasympathetic tone.

Remifentanil is rapidly acting with short context -sensitive half -life ,and metabolism by non specific plasma and tissue esterases . It exerts it effect by activating opioid receptors in the central nervous system ,reducing sympathetic outflow and inhibiting catecholamine release.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant Blinded

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • ASA1 AND ASA2.

排除标准

  • 未提供

研究者

发起方
Dr Shibani Kairi
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Shibani Kairi

Silchar medical college and hospital

研究点 (1)

Loading locations...

相似试验